Variables | Cases | KOR mRNA | ||
---|---|---|---|---|
T < N (n = 51) | T ≥ N (n = 13) | P | ||
Gender | ||||
Female | 8 | 5 | 3 | 0.196 |
Male | 56 | 46 | 10 | |
Age, years | ||||
≤ 50 | 28 | 22 | 6 | 0.845 |
> 50 | 36 | 29 | 7 | |
HBsAg | ||||
Negative | 8 | 6 | 2 | 0.725 |
Positive | 56 | 45 | 11 | |
Child-Pugh classificationa | ||||
A | 61 | 49 | 12 | 0.566 |
B | 3 | 2 | 1 | |
Serum AFP, ng/ml | ||||
≤ 20 | 30 | 21 | 9 | 0.070 |
> 20 | 34 | 30 | 4 | |
Tumor Number | ||||
Single | 48 | 37 | 11 | 0.370 |
Multiple | 16 | 14 | 2 | |
Tumor size, cm | ||||
≤ 5 | 35 | 24 | 11 | 0.015* |
> 5 | 29 | 27 | 2 | |
Tumor capsule | ||||
No/incomplete | 31 | 23 | 8 | 0.290 |
Yes | 33 | 28 | 5 | |
Vascular invasion | ||||
No | 58 | 46 | 12 | 0.816 |
Yes | 6 | 5 | 1 | |
Liver cirrhosis | ||||
Absent | 11 | 7 | 4 | 0.146 |
Present | 53 | 44 | 9 | |
Differentiation grade | ||||
I / II | 34 | 23 | 11 | 0.011* |
III/IV | 30 | 28 | 2 | |
TNM stage | ||||
I | 36 | 25 | 11 | 0.021* |
II/III | 28 | 26 | 2 |